IL27 and colitis: Oral delivery of recombinant IL-27 food-grade bacterium Lactococcus lactis ameliorates the murine colitis in a T cell-dependent colitis model, including improving survival, decreasing clinical score and pathologic score, downregulating inflammatory cytokines, and increasing IL-10 [56].